Psoriasis

	10/14/2009	Fumaric Acid Ester Safe and Effective Against Psoriasis in Patients Receiving Medication for Comorbidities: Presented at EADV - (DGDispatch)
	10/14/2009	Infliximab More Effective Than Methotrexate in Patients With Moderate to Severe Plaque Psoriasis: Presented at EADV - (DGDispatch)
	10/13/2009	Patients With Psoriasis Experience Improved Quality of Life Following Adalimumab Treatment: Presented at EADV - (DGDispatch)
	10/13/2009	Adalimumab Yields Fast and Sustainable Scalp and Nail Results in Patients With Psoriasis: Presented at EADV - (DGDispatch)
	10/13/2009	Comorbidities of Psoriasis Create Higher Healthcare Costs: Presented at EADV - (DGDispatch)
	10/12/2009	New Interleukin-12/23 Monoclonal Antibody Effective Against Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch)
	10/12/2009	Systemic Treatment With Biologics, Especially Infliximab, Is the Most Cost-Effective Therapy for Patients With Mild to Severe Psoriasis: Presented at EADV - (DGDispatch)
	10/12/2009	Continuous Treatment With Etanercept Effective in Controlling Symptoms of Moderate to Severe Psoriasis: Presented at EADV - (DGDispatch)
	09/25/2009	FDA Approves Ustekinumab for Moderate to Severe Psoriasis - (DGNews)
	09/23/2009	Ustekinumab Approved by NICE for Moderate to Severe Plaque Psoriasis - (DGNews)
	08/05/2009	FDA: Cancer Risk, New-Onset Psoriasis Warning Required for All TNF Blockers - (DGNews)
	06/15/2009	Psoriasis Associated With Cardiovascular Disease, Increased Mortality - (DGNews)
	06/15/2009	Chondroitin Sulphate Effective in Patients With Concomitant Knee Osteoarthritis and Psoriasis: Presented at EULAR - (DGDispatch)
	06/15/2009	Golimubab Shows Long-Term Efficacy in Treatment of Psoriatic Arthritis: Presented at EULAR - (DGDispatch)
	06/10/2009	Nationwide Recall of Remaining Batches of Efalizumab Initiated in Europe - (DGDispatch)
	05/11/2009	Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study) (BMJ)
	04/20/2009	Psoriasis Associated With Hypertension, Diabetes in Women - (DGNews)
	04/08/2009	Manufacturer of Efalizumab Announces Voluntary Withdrawal From US Market - (DGNews)
	04/07/2009	Golimumab Significantly Improves Active Psoriatic Arthritis, Nail Psoriasis - (DGNews)
	03/16/2009	Acitretin Therapy May Help Reduce Nail Psoriasis Symptoms - (DGNews)
	03/11/2009	Adalimumab Benefits Broad Span of Psoriasis Patients: Presented at AAD - (DGDispatch)
	03/10/2009	Etanercept Provides Sustained Efficacy and Safety Benefits in Patients With Psoriasis: Presented at AAD - (DGDispatch)
	03/10/2009	Ustekinumab Better Than Etanercept in Plaque Psoriasis: Presented at AAD - (DGDispatch)
	03/10/2009	Calcipotriol Plus Betamethasone Dipropionate Formulation Effective in Scalp Psoriasis: Presented at AAD - (DGDispatch)
	03/09/2009	Clobetasol Propionate Spray Followed by Calcitriol Ointment Effective for Plaque Psoriasis: Presented at AAD - (DGDispatch)
	03/09/2009	Ustekinumab Effective in Broad Span of Psoriasis Patients: Presented at AAD - (DGDispatch)
	02/19/2009	EMEA Recommends Suspension of Efalizumab, FDA Continues Its Safety Review - (DGNews)
	02/11/2009	Ustekinumab Reduces Symptoms of Psoriatic Arthritis, Diminishes Skin Lesions - (DGNews)
	02/03/2009	FDA Approves Calcitriol for Mild-to-Moderate Plaque Psoriasis - (DGNews)
	01/22/2009	Ustekinumab Approved in EU for Moderate to Severe Plaque Psoriasis - (DGNews)